rectal adenocarcinoma
Showing 1 - 25 of 53
Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Kaliningrad (Right hemicolectomy, Left hemicolectomy, Sigmoid colon
Recruiting
- Colorectal Cancer
- +5 more
- Right hemicolectomy
- +6 more
-
Kaliningrad, Kaliningrad Region, Russian FederationBaltic Federal University
Sep 15, 2023
Rectal Cancer Patients Based on ctDNA-MRD Technology
Recruiting
- Rectal Adenocarcinoma
- +3 more
- MRD detection
-
Guangzhou, Guangdong, ChinaWeiWei Xiao
Jul 31, 2023
Colon Cancer, Rectal Cancer, Colon Adenocarcinoma Trial in Seoul (Monofix)
Completed
- Colon Cancer
- +3 more
- Monofix
-
Seoul, Gangnam, Korea, Republic ofSamsung Medical Center
May 14, 2023
Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma Trial in San Francisco (Dietary intervention via Text
Not yet recruiting
- Colon Adenocarcinoma
- +2 more
- Dietary intervention via Text Messaging
- +2 more
-
San Francisco, California
- +1 more
Feb 17, 2023
Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,
Active, not recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
-
Anchorage, Alaska
- +797 more
Jan 9, 2023
Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,
Recruiting
- Adenocarcinoma of the Rectum
- +4 more
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,
Completed
- Rectal Adenocarcinoma
- +4 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +1 more
Jan 3, 2023
Improve Organ Preserving Strategies in Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2022
Rectal Adenocarcinoma, Rectum Tumor, Rectum Carcinoma Trial in Helsinki, Tampere, Turku (Oral Antibiotics, Placebo, Mechanical
Active, not recruiting
- Rectal Adenocarcinoma
- +7 more
- Oral Antibiotics
- +2 more
-
Helsinki, Finland
- +2 more
Nov 16, 2022
Quality of Life and Utilities Following Surgical Treatment of
Recruiting
- Rectal Adenocarcinoma
- +13 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States
Active, not recruiting
- Rectal Adenocarcinoma
- +2 more
- Capecitabine
- +6 more
-
Birmingham, Alabama
- +649 more
Aug 5, 2022
Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Washington (Atezolizumab, Bevacizumab)
Not yet recruiting
- Colon Adenocarcinoma
- +6 more
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jul 28, 2022
Rectal Adenocarcinoma Trial in Milwaukee (Capecitabine, Initial Dose of Radiation before Dose Escalation, Cohort A: Dose
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +5 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jul 19, 2022
Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)
Active, not recruiting
- Rectal Adenocarcinoma
- LY2157299
- +3 more
-
Portland, OregonProvidence Cancer Center
Mar 22, 2022
Strategy for Rectal Cancer. Can we ProvideMore Precise and
Active, not recruiting
- Rectal Cancer
- +2 more
-
Aalborg, DenmarkAalborg University Hospital
Mar 1, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)
Not yet recruiting
- Rectal Adenocarcinoma
- +8 more
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 Trial in Los Angeles (drug, radiation,
Recruiting
- Locally Advanced Rectal Carcinoma
- +9 more
- Capecitabine
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 13, 2022
Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,
Active, not recruiting
- Colon Adenocarcinoma
- +8 more
- Clobetasol Propionate
- +3 more
-
Phoenix, Arizona
- +21 more
Jan 5, 2022
Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma Trial in United States (Cabozantinib, Nivolumab)
Recruiting
- Colorectal Adenocarcinoma
- +6 more
-
Aurora, Colorado
- +4 more
Nov 19, 2021
Young-Onset Colorectal Cancer
Active, not recruiting
- Colon Adenocarcinoma
- +2 more
- Biospecimen Collection
- +3 more
-
Conroe, Texas
- +4 more
Nov 30, 2021
Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)
Withdrawn
- Rectal Adenocarcinoma
- Chemoradiation
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Nov 2, 2021
Rectal Adenocarcinoma Trial in Baltimore (FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}, Low dose fractionated
Terminated
- Rectal Adenocarcinoma
- FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
- Low dose fractionated radiation therapy (LDFRT)
-
Baltimore, MarylandUmmc Msgcc
Oct 6, 2021